Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 37Lymphoma 37Lymphoma, Follicular 33Lymphoma, Large B-Cell, Diffuse 30Lymphoma, Mantle-Cell 22Lymphoma, B-Cell, Marginal Zone 13Leukemia, Lymphocytic, Chronic, B-Cell 13Waldenstrom Macroglobulinemia 9Lymphoma, Large-Cell, Immunoblastic 9Burkitt Lymphoma 9Lymphoma, B-Cell 6Lymphoma, Large-Cell, Anaplastic 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 2Leukemia 2Recurrence 1Orbital lymphoma 1Oncology Patients Receiving Chemotherapy 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, AIDS-Related 1Lymphatic Diseases 1Immunoproliferative Disorders 1Immune System Diseases 1Graft vs Host Disease 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

ibritumomab tiuxetan 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Orbital lymphoma × ibritumomab tiuxetan × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡